Nyxoah (NASDAQ:NYXH – Get Free Report) and Ayr Wellness (OTCMKTS:AYRWF – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation.
Insider & Institutional Ownership
0.9% of Ayr Wellness shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by insiders. Comparatively, 8.1% of Ayr Wellness shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of current recommendations and price targets for Nyxoah and Ayr Wellness, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nyxoah | 1 | 1 | 2 | 0 | 2.25 |
| Ayr Wellness | 0 | 0 | 0 | 0 | 0.00 |
Risk & Volatility
Nyxoah has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500. Comparatively, Ayr Wellness has a beta of 1.79, suggesting that its share price is 79% more volatile than the S&P 500.
Valuation & Earnings
This table compares Nyxoah and Ayr Wellness”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nyxoah | $11.33 million | 5.03 | -$101.92 million | ($2.52) | -0.58 |
| Ayr Wellness | $463.63 million | 0.00 | -$359.31 million | ($1.62) | N/A |
Nyxoah has higher earnings, but lower revenue than Ayr Wellness. Nyxoah is trading at a lower price-to-earnings ratio than Ayr Wellness, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Nyxoah and Ayr Wellness’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nyxoah | -443.16% | -178.90% | -81.83% |
| Ayr Wellness | N/A | N/A | N/A |
Summary
Ayr Wellness beats Nyxoah on 7 of the 12 factors compared between the two stocks.
About Nyxoah
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
About Ayr Wellness
Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.
Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.
